CNAT Overview
Upcoming Projects (CNAT)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (CNAT)
-
Don’t see a project related to the company you care about? Create your own!
Upcoming & Overdue Catalysts (CNAT)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (CNAT)
-
FDA Grants Conatus Fast Track Designation for Development of Emricasan in liver cirrhosis caused by NASH
Ticker: CNAT
Occurred on: Feb 03, 2016 -
Conatus Achieves Positive Results with Emricasan in Initial Stage of Phase 2 Liver Cirrhosis Clinical Trial
Ticker: CNAT
Occurred on: Jan 05, 2016
Strategic Initiatives (CNAT)
-
Novartis (NVS) Agrees to Exclusive Worldwide License Agreement for Contaus Pharma's (CNAT) Orally Active Pan-Caspase Inhibitor Emricasan
Tickers: NVS, CNAT
Announcement Date: Dec 19, 2016
